Lebrikizumab for nasal polyps and sinusitis
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This trial tests a new injectable medicine (lebrikizumab) for people with chronic sinusitis and nasal polyps that steroid treatments haven't controlled. It aims to reduce polyp size and improve breathing, smell, and congestion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic sinusitis and have nasal polyps on both sides, confirmed by a doctor with a scope.
- You have moderate to severe nasal congestion (score 2 or 3 out of 3) and at least one other symptom like loss of smell or runny nose.
- You have taken steroid pills or had sinus surgery for polyps in the last 2 years, or you cannot take steroids for medical reasons.
- Your nasal polyps must be at least a 5 on an 8-point severity scale (doctor will check).
- If you have asthma, it must be stable for 3 months on your regular medication.
- You have not had any sinus surgery in the last 6 months, and no certain treatments like other biologics or immunosuppressants recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection called LP-003 for people with nasal polyps and chronic sinusitis. It aims to reduce symptoms like nasal congestion and improve quality of life. You may qualify if you have tried other treatments and still have symptoms.
This trial tests an investigational medication called AK139 for people with chronic sinusitis and nasal polyps. The treatment aims to reduce nasal congestion and polyp size, potentially improving symptoms.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This trial compares a newer biologic drug (anti-IL-5) plus simple polyp removal to a more extensive sinus surgery. It's for people with chronic sinusitis and nasal polyps who haven't gotten better with standard treatments.
This study is looking for markers in the blood that can predict how well certain biologic drugs work for people with chronic sinusitis and nasal polyps. It may help find the right treatment for you if your symptoms are not controlled with standard sprays or after surgery.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.